Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
9.89
+0.88 (9.71%)
Aug 28, 2026, 2:24 PM EDT - Market open
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $19.25 million as of August 28, 2026. Its market cap has decreased by -28.47% in one year.
Market Cap
19.25M
Enterprise Value
12.24M
1-Year Change
-28.47%
Ranking
Category
Stock Price
$9.89
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $19.25M, a decrease of -93.40%. That is a compound annual growth rate of -22.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 19.25M | 45.46% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 18.53M |
| Lipocine | 18.38M |
| Cyclerion Therapeutics | 18.38M |
| BioCardia | 17.71M |
| Citius Pharmaceuticals | 17.27M |
| Tempest Therapeutics | 17.26M |
| BioVie | 16.52M |
| Pluri | 16.51M |